(Q37808130)

23 August 2017

title

The role of red yeast rice for the physician (English)

1 reference

23 August 2017

Ram Y Gordon

1

1 reference

23 August 2017

David J Becker

series ordinal

2

1 reference

23 August 2017

language of work or name

1 reference

1 February 2011

1 reference

Current Atherosclerosis Reports

23 August 2017

published in

1 reference

23 August 2017

volume

13

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

73-80

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-010-0145-0

23 August 2017

exact match

0 references

cites work

Constituents of red yeast rice, a traditional Chinese food and medicine

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Lipid-lowering efficacy of red yeast rice in a population intolerant to statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Nutritional supplements and serum lipids: does anything work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Management of the patient with statin intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Statin-associated myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Risks associated with statin therapy: a systematic overview of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Outcomes in 45 patients with statin-associated myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Symptomatic myopathy due to red yeast rice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Chinese red rice-induced myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Symptomatic hepatitis associated with the use of herbal red yeast rice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Balancing randomized trials with anecdote.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Is red yeast rice a suitable alternative for statins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Narrative review: statin-related myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

How do you treat patients with myalgia who take statins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

The role of coenzyme Q10 in statin-associated myopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Effect of combining psyllium fiber with simvastatin in lowering cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Decreasing LDL cholesterol and medication cost with every-other-day statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0145-0

Dietary supplement or drug? The case of cholestin

21 January 2018

1 reference

12 December 2020

Expanding Statin Use to Help More At-Risk Patients Is Causing Financial Heartburn

1 reference

12 December 2020

Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products

1 reference

12 December 2020

HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study

1 reference

12 December 2020

Anaphylaxis due to Monascus purpureus-fermented rice (red yeast rice)

1 reference

12 December 2020

Ask the doctor. What is the story on using red yeast rice to lower cholesterol? You have warned readers against using it in the past, but I heard about a new study that shows it works. Are you ready to admit you are wrong on this one?

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.

1 reference

12 December 2020

Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement

1 reference

12 December 2020

Citrinin, an inhibitor of cholesterol synthesis

1 reference

12 December 2020

Effects of once weekly rosuvastatin among patients with a prior statin intolerance

1 reference

12 December 2020

Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.32.852

Identifiers

DOI

10.1007/S11883-010-0145-0

1 reference

23 August 2017

1 reference